StockSelector.com
  Research, Select, & Monitor Thursday, April 26, 2018 11:41:48 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
VBL Therapeutics$2.17($.03)(1.36%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

VBL Therapeutics has an overall rank of 3346 out of 6913 stocks based on 4 positive rankings and 4 negative rankings.

Positive Rankings
Up EPS Surprise
VBL Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Target Prices
The average analysts' target price is $3.00 for VBL Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, VBL Therapeutics is ranked 346.
Debt-to-Equity
VBL Therapeutics rank is 364
Price-to-Book
VBL Therapeutics rank is 1025
Negative Rankings
Negative Net Margin
VBL Therapeutics rank is 504
Negative ROE
VBL Therapeutics rank is 936
Negative ROA
VBL Therapeutics rank is 974
Price-to-Sales
VBL Therapeutics rank is 1143







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.